VALPHARMA INTERNAT S P A has a total of 21 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Italy, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and foods and drinks are ARAFARMA GROUP S A, BEIJING WONNER BIOTECH LTD CO and PHYSICA PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United States | 4 | |
#4 | Canada | 3 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Food shaping |
# | Name | Total Patents |
---|---|---|
#1 | Avanessian Serozh | 20 |
#2 | Valducci Roberto | 20 |
#3 | Alighieri Tiziano | 4 |
#4 | Tiziano Alighieri | 1 |
#5 | Avanessian Serozh Valducci Roberto | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015193788A1 | Formulation for oral administration containing mesalazine | |
WO2015018794A1 | A pharmaceutical composition containing ropinirole hcl administrable by oral route, and manufacturing method thereof | |
WO2015014987A1 | A modified-release oral pharmaceutical formulation containing gliclazide | |
WO2013190097A1 | Formulations for the preparation of immediate-release tablets for oral administration containing low-dose mifepristone, tablets thus obtained and their preparation process | |
WO2013190098A1 | Formulations for the preparation of immediate-release tablets for oral use containing low-dose mifepristone for the treatment of endometriosis, tablets thus obtained and their preparation process | |
ZA200610466B | Modified release formulation of Lithium Carbonate and method for the preparation thereof |